Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group (Q74590600)
scientific article published on 01 March 1999
Language:
(P31) (Q13442814)
(P304) 427-435
(P433) 3 Pt 1
(P478) 103
(P577) Monday, March 1, 1999
(P921) (Q35869)
(P1433) (Q7743550)
(P1476) "Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group" (language: en)
(P2093) J M FitzGerald
K R Chapman
G Della Cioppa
D Stubbing
M S Fairbarn
M D Till
R Brambilla
(P2860) (Q67525284)
(Q42594253)
(Q40541194)
(Q72609110)
(Q34667831)
(Q33821265)
(Q34241868)
(Q39513510)
(Q36274606)
(Q35181695)
(Q67522229)
(Q72232753)
(Q72678975)
(Q71927119)
(Q71459994)
(Q44996590)
(Q67522227)
(Q71810390)
(Q71723661)
(Q33604886)
(Q71131758)
(Q72229770)
(Q67522235)
(Q70708524)
(Q69109737)
(Q43431488)
(Q41197357)
(Q52701671)
(Q67525282)
(Q53723061)
(Q33775495)
(Q72957651)
(Q34554363)
(Q71089909)
(Q69914430)
(Q53789780)
(Q41453348)
(Q39491549)
other details
description scientific article published on 01 March 1999

External Links